BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Nabriva Therapeutics, Equity Bancshares, Revlon and AAC Holdings and Encourages Investors to Contact the Firm
03. Juli 2019 08:30 ET | Bragar Eagel & Squire
NEW YORK, July 03, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders Nabriva Therapeutics Plc,...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against KushCo Holdings, Nabriva Therapeutics, Equity Bancshares, and Revlon and Encourages Investors to Contact the Firm
27. Juni 2019 21:30 ET | Bragar Eagel & Squire
NEW YORK, June 27, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of KushCo Holdings, Inc.,...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm
14. Juni 2019 22:00 ET | Bragar Eagel & Squire
NEW YORK, June 14, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Indivior PLC, Boston...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm
05. Juni 2019 22:00 ET | Bragar Eagel & Squire
NEW YORK, June 05, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Indivior PLC, Boston...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm
30. Mai 2019 05:00 ET | Bragar Eagel & Squire
NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Indivior PLC, Boston...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm
23. Mai 2019 05:00 ET | Bragar Eagel & Squire
NEW YORK, May 23, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Indivior PLC, Boston...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm
17. Mai 2019 05:00 ET | Bragar Eagel & Squire
NEW YORK, May 17, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Indivior PLC, Boston...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Nabriva Therapeutics plc (NASDAQ: NBRV) and Encourages Nabriva Investors to Contact the Firm
09. Mai 2019 21:00 ET | Bragar Eagel & Squire
NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. is Investigating Nabriva Therapeutics plc (NBRV) on Behalf of Stockholders and Encourages NBRV Investors to Contact the Firm
02. Mai 2019 22:11 ET | Bragar Eagel & Squire
NEW YORK, May 02, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Nabriva Therapeutics plc (NASDAQ: NBRV). Our investigation concerns whether...